Safety First: Exploring the Interchangeability of Biosimilars

The use of biological products has increased dramatically in recent years. Biosimilar products have increased access to biologics utilized in the treatment of many chronic illnesses. Regulation to reduce drug costs and improve patient adherence can increase the risk of medication errors when it is not appropriately administered. This program aims to assist pharmacy staff navigating the complex and continuously evolving landscape of therapeutic equivalence and interchangeability to ensure the safe and effective delivery of patient care.